Triple negative/basal-like breast cancer (15.2%) is more common in younger women, particularly those with BRCA1 gene mutations, while the non-luminal HER2-positive subtype is ER- and PR- negative and, although not as common, tends to grow faster than luminal subtypes (13.7%) [6]. Here, ERBB2 is linked to breast carcinoma.